Microsurgical resection, endovascular means and stereotactic radiotherapy are the major treatments of cerebral arteriovenousmalformations (AVM) and each method has its own limitations. Preoperativefractionation embolization can reduce bleeding and surgical risk, however, patients have to experience repeated pain due to the repeated treatments, and face the risk of rupture of AVM during treatment. The purpose of this study is to evaluate the advantages and safety of combined surgical and endovascular. One hundred and ninety-five patients were successfully completed with combination of endovascular therapy and craniotomy in the hybrid operating room from February 2016 to July 2017 in Beijing Tiantan Hospital. We get our initial experience of combined surgical and endovascular procedures in hybrid operating room (OR) in the treatment of cerebral AVM.Hybrid operation can improve the ratio of total resection and efficacy ofsurgery of cerebral AVM, and reduce post-operative complications, medical costs and the repeated pain due to the repeated DSA examinations.
Professor Jizong Zhao, Academician of the Chinese Academy of Sciences. Prof. Zhao is the director, doctoral supervisor, and Chief of Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University. Prof. Zhao also serves as the Member of the Expert Group of the Academic Degrees Committee of the State Council, Director of China National Clinical Research Center for Neurological Diseases, Chairman of the 4?6th Chinese Medical Association Neurosurgery Branch, President of the Chinese Stroke Society, member of the Executive Committee of the World Neurosurgical Union (WFNS), Nomination Committee Member of the United States ANNS, Chairman of the Committee of the Dandy Neurosurgery Society of China, director of the National Higher Education Medical Textbook Research Council, chief editor of Chinese Neurosurgical Journal, deputy editor of Chinese Medical Journal and the Chinese Medical Journal (English version), editor of eight international journals in the field of neurosurgery, including Journal of Clinical Neuroscience.
Dr. Zhao’s research mainly focuses on cerebrovascular disease and brain tumor. He was the principal investigator of China’s ninth, tenth and eleventh Five-Year Plan for Science & Technology Support and honored with National Science & Technology Progress Awards.Prof. Zhao published more than 490 peer-reviewed articles papers, including over 90 SCI included articles and 9 books in the field of neurosurgery. As a world-wide recognized neurosurgeon and clinical neuroscience researcher, Dr. Zhao also serves on the editorial boards of seven scientific journals including Neurosurgical Review, Journal of Clinical Neuroscience and Neurosurgery.